drugset / Trial / NCT06630845
Comparison of Whole Body DWI to FDG PET
Recruiting
30 enrolled
University of California, San Francisco
GE Healthcare · collabSociety of Abdominal Radiology · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.
Timeline
- Start
- 2025-02-06
- Primary completion
- 2027-10-31
- Completion
- 2029-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | 5 mbq | Intravenous |
| Subject | 18F-FDG | Diagnostic / imaging agent | 10 mbq | Intravenous |